Sources of elevated serum androgens in postmenopausal women who develop breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 4, 2001, Pages 407-410

  Dorgan, Joanne F ^a   Boudou, Philippe ^b   Stanczyk, Frank Z ^c   Longcope, Christopher ^d   Tejpar, Aliya A ^e   Falk, Roni T ^f   Schussler, Nicki ^g   Stephenson, Hugh E ^h  

^a FOX CHASE CANCER CENTER   (United States)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e Salomon Smith Barney   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g INFORMATION MANAGEMENT SERVICES INC   (United States)

^h UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYANDROSTENEDIONE; ANDROGEN; ANDROSTENEDIONE; ESTROGEN;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES;

ADRENAL GLANDS; AGED; ANDROSTENEDIONE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; OVARY; POSTMENOPAUSE; RISK FACTORS;

EID: 0034894382     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Relationship of prediagnostic serum estrogen and androgen levels to breast cancer risk
2. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3β,17β-diol to risk of breast cancer in postmenopausal women
3. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer
4. Serum sex hormone levels after menopause and subsequent breast cancer
5. A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey
6. Plasma sex steroid hormone levels and risk of breast cancer in postmenopansal women
7. Elevated serum estradiol and testosterone concentrations are associated with a high risk of breast cancer
8. Adrenal and gonadal androgen secretion in normal females
9. The endocrinology of the menopause
10. Hormonal dynamics associated with the menopause
11. Radioimmunoassay of 11β-hydroxyandrostenedione in laboratory diagnostics of selected endocrine disorders
12. Serum 11β-hydroxyandrostenedione as an indicator of the source of excess androgen production in women with polycystic ovaries
13. 11β-hydroxyandrostenedione: A marker of adrenal function in hirsutism
14. Is 11β-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?
15. The ratio of androstenedione: 11β-hydroxyandrostenedione is an important marker of adrenal androgen excess in women
16. Investigation of adrenal function in women with oligomenorrhea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test
17. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperandrogenism: Role of adrenal and ovarian cytochrome P450c17α
18. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome
19. Endocrine abnormalities in women with breast cancer
20. Effect of androgen on adrenal steroidogenesis in normal women
21. Androgen-estrogen production rates in postmenopausal women with breast cancer
22. 11β-Hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries
23. Studies to confirm the source of 11β-Hydroxyandrostenedione
24. Evidence for the ovarian secretion of 11-β-hydroxyandrostenedione in women with polycystic ovaries
25. Metabolic clearance rate of dehydroepiandrosterone sulfate, its metabolism to lestosterone, and its intrafollicular metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone in vivo